LPL Financial LLC Invests $244,000 in Grail, Inc. (NASDAQ:GRAL)

LPL Financial LLC acquired a new position in shares of Grail, Inc. (NASDAQ:GRAL) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 13,669 shares of the company’s stock, valued at approximately $244,000.

A number of other institutional investors and hedge funds have also made changes to their positions in GRAL. Douglas Lane & Associates LLC acquired a new position in shares of Grail during the fourth quarter worth about $3,034,000. A. D. Beadell Investment Counsel Inc. acquired a new position in shares of Grail during the fourth quarter worth about $430,000. FNY Investment Advisers LLC acquired a new position in shares of Grail during the fourth quarter worth about $26,000. 180 Wealth Advisors LLC purchased a new stake in Grail during the fourth quarter worth approximately $1,681,000. Finally, B & T Capital Management DBA Alpha Capital Management acquired a new position in Grail in the fourth quarter valued at approximately $387,000.

Grail Price Performance

Shares of Grail stock opened at $36.90 on Tuesday. Grail, Inc. has a 1 year low of $12.33 and a 1 year high of $63.99. The company’s fifty day moving average is $30.83 and its two-hundred day moving average is $24.58.

Grail (NASDAQ:GRAL) last issued its quarterly earnings data on Thursday, February 20th. The company reported ($1.86) earnings per share (EPS) for the quarter, topping the consensus estimate of ($4.41) by $2.55. The business had revenue of $38.25 million for the quarter, compared to analysts’ expectations of $35.33 million. On average, sell-side analysts anticipate that Grail, Inc. will post -15.15 earnings per share for the current year.

Insiders Place Their Bets

In other news, CFO Aaron Freidin sold 1,816 shares of Grail stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $31.20, for a total value of $56,659.20. Following the sale, the chief financial officer now owns 335,170 shares of the company’s stock, valued at $10,457,304. The trade was a 0.54 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Robert P. Ragusa sold 7,625 shares of Grail stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $31.21, for a total transaction of $237,976.25. Following the completion of the sale, the chief executive officer now directly owns 828,662 shares in the company, valued at approximately $25,862,541.02. The trade was a 0.91 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 11,550 shares of company stock valued at $360,436.

Analysts Set New Price Targets

GRAL has been the topic of a number of recent analyst reports. Canaccord Genuity Group initiated coverage on shares of Grail in a research report on Monday, April 21st. They issued a “buy” rating and a $32.00 target price on the stock. Morgan Stanley increased their target price on shares of Grail from $16.00 to $20.00 and gave the company an “equal weight” rating in a research report on Tuesday, March 18th.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.